Pregnancy augments G protein estrogen receptor (GPER) induced vasodilation in rat uterine arteries via the nitric oxide - cGMP signaling pathway

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Tropea, Teresa ^a   De Francesco, Ernestina Marianna ^a   Rigiracciolo, Damiano ^a   Maggiolini, Marcello ^a   Wareing, Mark ^b   Osol, George ^c   Mandalà, Maurizio ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; ESTROGEN RECEPTOR; G PROTEIN COUPLED ESTROGEN RECEPTOR; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; NITRIC OXIDE; PHENYLEPHRINE; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; GPR30 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; FETUS GROWTH; INCUBATION TIME; NONHUMAN; PLACENTA CIRCULATION; PREGNANCY OUTCOME; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; UTERINE ARTERY; VASODILATATION; ANIMAL; CYTOLOGY; METABOLISM; PHYSIOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYCLIC GMP; FEMALE; NITRIC OXIDE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; UTERINE ARTERY; VASODILATION;

EID: 84950996584     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141997     Document Type: Article

References (35)

1. Pastore MB, Jobe SO, Ramadoss J, Magness RR. Estrogen receptor-a and estrogen receptor-b in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow. Semin Reprod Med. 2012; 30:46-61. doi: 10.1055/s-0031-1299597 PMID: 22271294
2. Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Mol Endocrinol. 2006; 20:1707-14. PMID: 16396959
3. Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997; 45:607-17. PMID: 9367686
4. Kvingedal AM, Smeland EB. A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett. 1997; 407:59-62. PMID: 9141481
5. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, Heng HH, et al. Discovery of three novel Gprotein coupled receptor genes. Genomics 1998; 47:310-3. PMID: 9479505
6. Owman C, Blay P, Nilsson C, Lolait SJ. Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem Biophys Res Commun.1996; 228:285-92. PMID: 8920907
7. Takada Y, Kato C, Kondo S, Korenaga R, Ando J. Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun. 1997; 240:737-41. PMID: 9398636
8. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G-protein in human breast cancer cells. Endocrinology 2005; 146:624-32. PMID: 15539556
9. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307:1625-30. PMID: 15705806
10. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol. 2010; 204:105-114. doi: 10.1677/JOE-09-0242 PMID: 19767412
11. De Francesco EM, Lappano R, Santolla MF, Marsico S, Caruso A, Maggiolini M. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs). Breast Cancer Res. 2013; 15:R64. PMID: 23947803
12. De Francesco EM, Pellegrino M, Santolla MF, Lappano R, Ricchio E, Abonante S, et al. GPER mediates activation of HIF1α/VEGF signaling by estrogens. Cancer Res. 2014; 74:4053-64. doi: 10.1158/0008-5472.CAN-13-3590 PMID: 24894716
13. Lappano R, Rosano C, De Marco P, De Francesco EM, Pezzi V, et al. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol. 2010; 320:162-170. doi: 10.1016/j.mce.2010.02.006 PMID: 20138962
14. Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, et al. Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts. Environ Health Perspec. 2012; 120:1177-1182.
15. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR, et al. Effects of Atrazine on Estrogen Receptor α- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts. Environ Health Perspect. 2015 (in press).
16. Bologa CG, Revankar CM, Young SM., Edwards BS., Arterburn JB., Kiselyov AS, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol. 2006; 2:207-12. PMID: 16520733
17. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, et al. In vivo effects of a GPR30 antagonist. Nat Chem Biol. 2009; 5(6):421-7. doi: 10.1038/nchembio.168 PMID: 19430488
18. Meyer MR, Prossnitz ER, Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol. 2011; 55:17-25. doi: 10.1016/j.vph.2011.06.003 PMID: 21742056
19. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, et al. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 2009; 150:1722-30. doi: 10.1210/en.2008-1488 PMID: 19095739
20. Broughton BRS, Miller AA, Sobey CG. Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol. 2010; 298: H1055-H1061. doi: 10.1152/ajpheart.00878.2009 PMID: 20061543
21. Lindsey SH, Carver KA, Prossnitz ER, Chappell MC. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2. Lewis female rat. J Cardiovasc Pharmacol. 2011; May; 57 (5):598-603. PMID: 21326105
22. Haas E, Bhattacharya I, Brailoiu E. Regulatory Role of G Protein-Coupled Estrogen Receptor for Vascular Function and Obesity. Circ Res. 2009; 104(3):288-291. doi: 10.1161/CIRCRESAHA.108.190892 PMID: 19179659
23. Patkar S, Farr TD, Cooper E, Dowell FJ, Carswell HV. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery. Neurosci Res. 2011;Sep; 71(1):78-84. doi: 10.1016/j.neures.2011.05.006 PMID: 21624404
24. Lindsey SH, Liu L, Chappell MC. Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling. Steroids. 2014; 81:99-102. doi: 10.1016/j.steroids. 2013.10.017 PMID: 24246735
25. Mandala M, Osol G. Physiological remodeling of the maternal uterine circulation during Pregnancy. Basic Clin Pharmacol Toxicol. 2012;Jan; 110(1):12-8. doi: 10.1111/j.1742-7843.2011.00793.x PMID: 21902814
26. Colton I, Mandalà M, Morton J, Davidge ST, Osol G. Influence of constriction, wall tension, smooth muscle activation and cellular deformation on rat resistance artery vasodilator reactivity. Cell Physiol Biochem. 2012; 29(5-6):883-92. doi: 10.1159/000178465 PMID: 22613988
27. Osol G, Mandala M. Maternal uterine vascular remodeling during pregnancy. Physiology 2009; 24:58-71. doi: 10.1152/physiol.00033.2008 PMID: 19196652
28. Byers MJ, Zangl A, Phernetton TM, Lopez G, Chen DB, Magness RR. Endothelial vasodilator production by ovine uterine and systemic arteries: ovarian steroid and pregnancy control of ERalpha and ERbeta levels. J Physiol. 2005;May 15; 565(Pt 1):85-99. PMID: 15774511
29. Van der Heijden OW, Essers YP, Spaanderman ME, De Mey JG, van Eys GJ, Peeters LL. Uterine artery remodeling in pseudopregnancy is comparable to that in early pregnancy. Biol Reprod. 2005; 73 (6):1289-93. PMID: 16120827
30. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, et al. Differential effects of 17β- Estradiol on function and expression of estrogen receptor α, estrogen receptor β, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension. 2007; 49:1358-1363. PMID: 17452498
31. Arefin S, Simoncini T, Wieland R, Hammarqvist F, Spina S, Goglia L, et al. Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women. Maturitas. 2014; 78:123-30. doi: 10.1016/j.maturitas.2014.04.002 PMID: 24796498
32. Corcoran JJ, Nicholson C, Sweeney M, Charnock JC, Robson SC, Westwood M, et al. Human uterine and placental arterie sexhibit tissue-specific acute responses to 17b-estradiol and estrogen-receptors pecific agonists. Mol Hum Reprod. 2014; 20(5):433-41. doi: 10.1093/molehr/gat095 PMID: 24356876
33. Meyer MR, Baretella O, Prossnitz ER, Barton M. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. Pharmacology 2010; 86:58-64. doi: 10.1159/000315497 PMID: 20639684
34. Magness RR, Rosenfeld CR. Systemic and uterine responses to alpha-adrenergic stimulation in pregnant and nonpregnant ewes. Am J Obstet Gynecol. 1986; 155(4):897-904. PMID: 3766646
35. Yu X, Ma H, Barman SA, Liu AT, Sellers M, Stallone JN, et al. Activation of G protein-coupled estrogen receptor induces endothelium independent relaxation of coronary artery smooth muscle. Am J Physiol Endocrinol Metab. 2011; 301:E882-E888. doi: 10.1152/ajpendo.00037.2011 PMID: 21791623